SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) - ANVISA Registration 80002670095

Access comprehensive regulatory information for SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80002670095 and manufactured by RENYLAB QUÍMICA E FARMACÊUTICA LTDA. The registration is held by RENYLAB QUÍMICA E FARMACÊUTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ALAMAR TECNO CIENTÍFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80002670095
Registration Details
ANVISA Registration Number: 80002670095
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80002670095

25351372433201719

00562583000144

Company Information

Brazil
PT: BRASIL

Dates and Status

Sep 25, 2017

VIGENTE

09/18/2025 19:00:01